Markets | Phillips Financial

Skip to:

Markets Digest Vaccine News

Echoes from Monday’s encouraging news about a vaccine continue to ripple through the world – and the markets. To recap: Drugmaker Pfizer and its partner, BioNTech, announced Monday morning that their Phase III coronavirus vaccine trials indicated a strong 90% efficacy rate with minimal instances of side effects. We’re not out of the woods yet, […]

Continue Reading

Market Leaps at Positive Vaccine News

Few things are as encouraging as a glimpse at the light at the end of the tunnel. Pharmaceutical makers Pfizer and BioNTech announced Monday morning that their coronavirus vaccine has shown strong results through ongoing drug trials – a 90% efficacy rate with minimal side effects. This news immediately gave lift to the markets, adding another historic moment to a year chock-full of them.

Stock Market Soared in Spite of U.S. Presidential Election

It’s said markets hate uncertainty, but that wasn’t the case last week.

Despite tremendous uncertainty about the outcome of the United States election, major domestic and international stock indices moved higher and the CBOE Volatility Index, better known as Wall Street’s fear gauge, moved 35 percent lower.1 Ben Levisohn of Barron’s reported:2